Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers July 28, 2017
Pharmacy Choice - Pharmaceutical News - China Biologic Products to Report First Quarter of 2017 Financial Results - July 28, 2017

Pharmacy News Article

 4/21/17 - China Biologic Products to Report First Quarter of 2017 Financial Results

BEIJING, China, April 21, 2017 /PRNewswire/ China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release first quarter of 2017 financial results on Wednesday, May 3, 2017 after the market closes.

The Company's management will hold a conference call at 7:30 a.m. ET on Thursday, May 4, 2017, which is 7:30 p.m., Beijing Time on May 4, 2017, to discuss first quarter of 2017 results. Listeners may access the call by dialing:

US: 1 888 346 8982
International: 1 412 902 4272
Hong Kong: 800 905 945
China: 400 120 1203

A telephone replay will be available one hour after the conclusion of the conference call through May 11, 2017. The dial-in details are:

US: 1 877 344 7529
International: 1 412 317 0088
Passcode: 10106035

A live and archived webcast of the conference call will be available through the Company's investor relations website at

About China Biologic Products, Inc.

China Biologic is a leading plasma-based biopharmaceutical company in China. The Company's products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. China Biologic is headquartered in Beijing and manufactures over 20 different dosages of plasma-based products through its majority-owned subsidiary, Shandong Taibang Biological Products Co., Ltd., and its wholly-owned subsidiary, Guizhou Taibang Biological Products Co., Ltd. The Company also has an equity investment in Xi'an Huitian Blood Products Co., Ltd. The Company sells its products to hospitals and inoculation centers, as well as distributors, in China. For additional information, please see the Company's website,


China Biologic Products, Inc.
Mr. Ming Yin
Senior Vice President
Phone: +86-10-6598-3099

ICR Inc.
Mr. Bill Zima
Phone: +86-10-6583-7511 or +1-646-405-5191

To view the original version on PR Newswire, visit:

SOURCE China Biologic Products, Inc.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Jul 31: Obesity Management: Overview of Pharmacotherapy
Aug 01: Treatment of Depression and Anxiety in Older Adults
Aug 02: Adverse Drug Events: Risk Reduction & Documentation
Aug 03: Medication Use During Pregnancy & Lactation
Aug 07: Using Barcodes to Improve Medication Safety: Considerations for Pharmacists & Technicians
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement